More HeraMED Ltd news
HeraMED LtdASX: HMD

Sheba HeraBEAT Clinical Trial Completed - Excellent Results

Jul 18, 2022 at 11:19 PM EDT · Issued by HeraMED Ltd

Filed with ASX · Jul 18, 2022 at 11:19 PM EDT

On 6ix: 6ix.com/news/sheba-herabeat-clinical-trial-completed-excellent-results

Heramed Ltd has released a press release.

View Attachment

6ix hasn’t read this filing yet.

HeraMED Ltd on 6ix

Earlier from HeraMED

  • JHC agrees to full commercial rollout of HeraCAREJan 20, 2022
  • Reinstatement to Official QuotationJan 20, 2022
  • Response to ASX Price QueryNov 15, 2021
  • $2.39 million raised via a Convertible NoteOct 17, 2021
  • Positive Interim Results US Paid Pilot & 2nd Site ConfirmedSep 13, 2021

Later from HeraMED

  • HMD & e-Lovu Health Partnership for HeraCARE Deployment USJul 27, 2022
  • HeraMED Completes $4 Million Private PlacementAug 24, 2022
  • Ramsay Affiliated Melbourne Mothers Practice Adopts HeraCARENov 22, 2022
  • Successful First Phase - e-Lovu Initial Commercial RolloutFeb 19, 2023
  • Appendix 4E & Preliminary Final ReportFeb 28, 2023
All HeraMED news releases↗

Follow HeraMED into a list and get an email when it puts out news.

Follow HeraMED
  • About 6ix
  • Editorial & Sourcing
  • Corrections
  • Contact
  • Privacy
  • Terms
  • Disclaimer